Alpha-1 antitrypsin, a diagnostic and prognostic marker of vernal keratoconjunctivitis

Journal of Clinical and Diagnostic Research

Volumn 8, Issue 5, 2014, Pages 8-10

  Ahsan, Akif ^a   Salman, Khushtar A ^a   Alam, Sana ^a   Siddiqui, Anwar H ^a   Naeem, Syed Shariq ^a   Ahmad, Aquil ^a   Khan, Iqbal M ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

Alpha 1 antitrypsin; Trypsin inhibitory activity; Vernal keratoconjunctivitis

Indexed keywords

ALPHA 1 ANTITRYPSIN; TRYPSIN;

ADOLESCENT; ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; DRUG BLOOD LEVEL; ENZYME INHIBITION; FEMALE; HUMAN; INDIA; MALE; PROGNOSIS; SPECTROPHOTOMETRY; VERNAL CONJUNCTIVITIS; YOUNG ADULT;

EID: 84901286505     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2014/6342.4362     Document Type: Article

References (24)

1. Stahl JL and NP Barney, Ocular allergic disease. Curr Opin Allergy Clin Immunol, 2004; 4(5): 455-9.
2. Kawuma M. The clinical picture of vernal kerato-conjunctivitis in Uganda. Community Eye Health. 2001; 14(40): 66-7.
3. Bonini S, et al. Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term followup. Ophthalmology; 2000. 107(6): 1157-63.
4. Allansmith MR and RN Ross, Ocular allergy. Clin Allergy. 1988;18(1): 1-13.
5. Leonardi A. Vernal keratoconjunctivitis: pathogenesis and treatment. Prog Retin Eye Res; 2002. 21(3): 319-39.
6. Gabay C and I Kushner, Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999; 340(6): 448-54.
7. Volanakis JE, In: Koopmann WJ, Moreland LW eds. Acute-phase Proteins in Rheumatic Disease. Philadelphia: Lippincott Williams & Wilkins, 2005. 15.
8. Morgan K and NA Kalsheker, Regulation of the serine proteinase inhibitor (SERPIN) gene alpha 1-antitrypsin: a paradigm for other SERPINs. Int J Biochem Cell Biol. 1997; 29(12): 1501-11.
9. Schultze HE, K Heide, and H Haupt, alpha1-Antitrypsin from human serum. Klin Wochenschr. 1962; 40: 427-9.
10. Lomas DA and H. Parfrey, Alpha1-antitrypsin deficiency. 4: Molecular pathophysiology. Thorax. 2004; 59(6): 529-35.
11. Carrell RW, et al. Structure and variation of human alpha 1-antitrypsin. Nature. 1982; 298(5872): 329-34.
12. Korkmaz B, et al. Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases. Pharmacol Rev. 2010; 62(4): 726-59.
13. Chang YH, et al. Secretomic analysis identifies alpha-1 antitrypsin (A1AT) as a required protein in cancer cell migration, invasion, and pericellular fibronectin assembly for facilitating lung colonization of lung adenocarcinoma cells. Mol Cell Proteomics. 2012; 11(11): 1320-39.
14. Topic A, et al. Alpha-1-antitrypsin deficiency in Serbian adults with lung diseases. Genet Test Mol Biomarkers 2012;16(11): 1282-6.
15. Ghavami S, et al. Trypsin inhibitory capacity in vernal keratoconjunctivitis. Invest Ophthalmol Vis Sci. 2007; 48(1): 264-9.
16. Waheed, A. and A. Salhuddin, Isolation and characterization of a variant of ovomucoid. Biochem J. 1975; 147(1): 139-44.
17. Warsy AS. Alpha-1-antitrypsin in Saudi population. Journal of Islamic Academy of Sciences. 1989; 2(2): 85-8.
18. Ghavami S, et al. Alpha-1-antitrypsin phenotypes and HLA-B27 typing in uveitis patients in southeast Iran. Clin Biochem. 2005; 38(5): 425-32.
19. Carrell RW and DA Lomas, Conformational disease. Lancet. 1997; 350(9071): p. 134-8.
20. Hashemi M, et al. High prevalence of alpha 1 antitrypsin phenotypes in viral hepatitis B infected patients in Iran. Hepatol Res. 2005;33(4): 292-7.
21. Wasse H, et al. Increased plasma chymase concentration and mast cell chymase expression in venous neointimal lesions of patients with CKD and ESRD. Semin Dial. 2011; 24(6): 688-93.
22. Miyazaki M and S Takai. Tissue angiotensin II generating system by angiotensin-converting enzyme and chymase. J Pharmacol Sci. 2006; 100(5): 391-7.
23. Thorpe M, et al. Extended cleavage specificity of the mast cell chymase from the crab-eating macaque (Macaca fascicularis): an interesting animal model for the analysis of the function of the human mast cell chymase. Int Immunol. 2012; 24(12): 771-82.
24. Knoell DL, et al. Alpha 1-antitrypsin and protease complexation is induced by lipopolysaccharide, interleukin-1beta, and tumor necrosis factor-alpha in monocytes. Am J Respir Crit Care Med. 1998; 157(1): 246-55.